Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

Pituitary apoplexy induced by Gonadotropin-releasing hormone agonists for treating prostate cancer-report of first Asian case.

Huang TY, Lin JP, Lieu AS, Chen YT, Chen HS, Jang MY, Shen JT, Wu WJ, Huang SP, Juan YS.

World J Surg Oncol. 2013 Oct 2;11:254. doi: 10.1186/1477-7819-11-254.

PMID:
24088191
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Pituitary apoplexy after leuprolide.

Davis A, Goel S, Picolos M, Wang M, Lavis V.

Pituitary. 2006;9(3):263-5.

PMID:
16832587
[PubMed - indexed for MEDLINE]
3.

Pituitary apoplexy after leuprolide administration for carcinoma of the prostate.

Morsi A, Jamal S, Silverberg JD.

Clin Endocrinol (Oxf). 1996 Jan;44(1):121-4.

PMID:
8706284
[PubMed - indexed for MEDLINE]
4.

Gonadotropin-releasing hormone agonist-induced pituitary apoplexy in treatment of prostate cancer: case report and review of literature.

Hands KE, Alvarez A, Bruder JM.

Endocr Pract. 2007 Oct;13(6):642-6. Review.

PMID:
17954421
[PubMed - indexed for MEDLINE]
5.

Discovery of a pituitary adenoma following treatment with a gonadotropin-releasing hormone agonist in a patient with prostate cancer.

Massoud W, Paparel P, Lopez JG, Perrin P, Daumont M, Ruffion A.

Int J Urol. 2006 Jan;13(1):87-8.

PMID:
16448441
[PubMed - indexed for MEDLINE]
6.

[Two cases of non-functional gonadotroph adenoma pituitary apoplexy following GnRH-agonist treatment revealing gonadotroph adenoma and pseudopituitary apoplexy after GnRH administration].

Hernandez Morin N, Huet D, Hautecouverture M.

Ann Endocrinol (Paris). 2003 Jun;64(3):227-31. French.

PMID:
12910066
[PubMed - indexed for MEDLINE]
7.

Apoplexy in non functioning pituitary adenoma after one dose of leuprolide as treatment for prostate cancer.

Guerra Y, Lacuesta E, Marquez F, Raksin PB, Utset M, Fogelfeld L.

Pituitary. 2010;13(1):54-9. doi: 10.1007/s11102-009-0202-2. Review.

PMID:
19842040
[PubMed - indexed for MEDLINE]
8.

Delayed pituitary apoplexy in patient with advanced prostate cancer treated with gonadotrophin-releasing hormone agonists.

Sinnadurai M, Cherukuri RK, Moses RG, Nasser E.

J Clin Neurosci. 2010 Sep;17(9):1201-3. doi: 10.1016/j.jocn.2010.01.012. Epub 2010 Jun 3.

PMID:
20605467
[PubMed - indexed for MEDLINE]
9.

Discovery of a pituitary adenoma following a gonadotropin-releasing hormone agonist in a patient with prostate cancer.

Massoud W, Paparel P, Lopez JG, Perrin P, Daumont M, Ruffion A.

Int J Urol. 2006 Mar;13(3):303-4.

PMID:
16643633
[PubMed - indexed for MEDLINE]
10.

Pituitary apoplexy of a gonadotroph adenoma following gonadotrophin releasing hormone agonist therapy for prostatic cancer.

Reznik Y, Chapon F, Lahlou N, Deboucher N, Mahoudeau J.

J Endocrinol Invest. 1997 Oct;20(9):566-8.

PMID:
9413812
[PubMed - indexed for MEDLINE]
11.

Gonadotropin-releasing hormone: an update review of the antagonists versus agonists.

Van Poppel H, Klotz L.

Int J Urol. 2012 Jul;19(7):594-601. doi: 10.1111/j.1442-2042.2012.02997.x. Epub 2012 Mar 14. Review.

PMID:
22416801
[PubMed - indexed for MEDLINE]
12.

Pituitary apoplexy after leuprolide injection for ovum donation.

Engel G, Huston M, Oshima S, Beck C, Harsh G, Rosenthal MH, Camargo CA.

J Adolesc Health. 2003 Jan;32(1):89-93.

PMID:
12507807
[PubMed - indexed for MEDLINE]
13.

Pituitary apoplexy after leuprolide administration for carcinoma of the prostate: what's new?

Faustini-Fustini M.

Clin Endocrinol (Oxf). 1997 Mar;46(3):378. No abstract available.

PMID:
9156052
[PubMed - indexed for MEDLINE]
14.

Granulomas induced by subcutaneous injection of leuprorelin acetate.

Sakamoto R, Higashi Y, Mera K, Kanekura T, Kanzaki T.

J Dermatol. 2006 Jan;33(1):43-5.

PMID:
16469084
[PubMed - indexed for MEDLINE]
15.

Gonadotropin-releasing hormone-induced partial empty sella clinically mimicking pituitary apoplexy in a woman with a suspected non-secreting macroadenoma.

Foppiani L, Piredda S, Guido R, Spaziante R, Giusti M.

J Endocrinol Invest. 2000 Feb;23(2):118-21.

PMID:
10800766
[PubMed - indexed for MEDLINE]
16.

Pituitary apoplexy caused by luteinizing hormone-releasing hormone in prolactin-producing adenoma.

Hiroi N, Ichijo T, Shimojo M, Ueshiba H, Tsuboi K, Miyachi Y.

Intern Med. 2001 Aug;40(8):747-50.

PMID:
11518116
[PubMed - indexed for MEDLINE]
Free Article
17.

Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer.

Smith MR, McGovern FJ, Zietman AL, Fallon MA, Hayden DL, Schoenfeld DA, Kantoff PW, Finkelstein JS.

N Engl J Med. 2001 Sep 27;345(13):948-55.

PMID:
11575286
[PubMed - indexed for MEDLINE]
Free Article
18.

Pituitary apoplexy during treatment of cystic macroprolactinomas with cabergoline.

Balarini Lima GA, Machado Ede O, Dos Santos Silva CM, Filho PN, Gadelha MR.

Pituitary. 2008;11(3):287-92.

PMID:
17570067
[PubMed - indexed for MEDLINE]
19.

Life-threatening anaphylaxis to leuprorelin acetate depot: case report and review of the literature.

Fujisaki A, Kondo Y, Goto K, Morita T.

Int J Urol. 2012 Jan;19(1):81-4. doi: 10.1111/j.1442-2042.2011.02886.x. Epub 2011 Nov 3. Review.

PMID:
22050405
[PubMed - indexed for MEDLINE]
20.

Infarction followed by hemorrhage in pituitary adenoma due to endocrine stimulation test.

Matsuura I, Saeki N, Kubota M, Murai H, Yamaura A.

Endocr J. 2001 Aug;48(4):493-8.

PMID:
11603573
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk